• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Tresiba Pediatric Indication

anonymous

Guest
What impact can this have on Novo staying afloat and what insight can the field provide on if/how they will be pushing this?
Is it too little too late or can this provide some respite to concerns for our Q2 financial assessment?
 

<







What impact can this have on Novo staying afloat and what insight can the field provide on if/how they will be pushing this?
Is it too little too late or can this provide some respite to concerns for our Q2 financial assessment?


If they play their cards right they stand to make thousands of dollars.
 




Similar threads